| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0012700 | Intron-Exon-Intron | chr10:31661947-31771587 | chr10:31373018-31482658 | 156 nt | 0.3782 |
| hsa_ZEB1_0012800 | Exon-Exon | chr10:31661947-31784767 | chr10:31373018-31495838 | 216 nt | 0.4213 |
| hsa_ZEB1_0013000 | Exon-Exon | chr10:31661947-31799803 | chr10:31373018-31510875 | 1090 nt | 0.4119 |
| hsa_ZEB1_0013100 | Exon-Exon | chr10:31661947-31803636 | chr10:31373018-31514708 | 112 nt | 0.3750 |
| hsa_ZEB1_0013300 | Exon-Exon | chr10:31661954-31676195 | chr10:31373025-31387266 | 292 nt | 0.4144 |
| hsa_ZEB1_0013400 | Exon-Exon | chr10:31661954-31676727 | chr10:31373025-31387798 | 79 nt | 0.3671 |
| hsa_ZEB1_0013500 | Exon-Intron | chr10:31661954-31678589 | chr10:31373025-31389660 | 135 nt | 0.3852 |
| hsa_ZEB1_0013200 | Exon-Intron | chr10:31661954-31709678 | chr10:31373025-31420749 | 250 nt | 0.3120 |
| hsa_ZEB1_0013600 | Exon-Exon | chr10:31661998-31676727 | chr10:31373069-31387798 | 79 nt | 0.3671 |
| hsa_ZEB1_0013900 | Exon-Intron | chr10:31662051-31678589 | chr10:31373122-31389660 | 52 nt | 0.3654 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].